Bayer AG · Leverkusen Germany (German: BAY)
Key Bayer AG Financials
| Company Type | Public -(German: BAY) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $46,498.6 |
| 2010 Employees | 111,400 |
Bayer AG Stock Quote (Pink Sheets: BAYRY)(German: BAY)
| Latest 02/14/12 15:52:55 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $72.07 | 0.000 | 0.000 | $0.00 | $0.00 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Bayer AG Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 46,498.6 | 44,670.0 | 46,397.9 |
| Cost of Goods Sold | 22,664.9 | 21,691.5 | 23,194.7 |
| Gross Profit | 23,833.7 | 22,978.5 | 23,203.2 |
| Gross Profit Margin | 51.3% | 51.4% | 50% |
| SG&A Expense | 13,848.3 | 13,681.3 | 13,748.3 |
| Depreciation & Amortization | 4,712.4 | 4,025.9 | 3,836.7 |
| Operating Income | 3,617.8 | 2,986.8 | 4,995.3 |
| Operating Margin | 7.8% | 6.7% | 10.8% |
| Nonoperating Income | (675.9) | (1,628.1) | (1,674.5) |
| Nonoperating Expenses | (661.3) | -- | -- |
| Income Before Taxes | 2,280.7 | 2,680.1 | 3,320.8 |
| Income Taxes | 544.7 | 732.4 | 896.4 |
| Net Income After Taxes | 1,736.0 | 1,947.7 | 2,424.3 |
| Continuing Operations | 1,724.1 | 1,947.7 | 2,424.3 |
| Discontinued Operations | -- | 0.0 | 5.6 |
| Total Operations | 1,724.1 | 1,947.7 | 2,430.0 |
| Total Net Income | 1,724.1 | 1,947.7 | 2,430.0 |
| Net Profit Margin | 3.7% | 4.4% | 5.2% |
| Diluted EPS from Total Net Income | 2.08 | 2.44 | 3.13 |
| Dividends per Share | 1.37 | 2.01 | 1.90 |
All amounts in millions of US Dollars except per share amounts.
Bayer AG Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 3,763.6 | 3,905.5 | 2,951.5 |
| Net Receivables | 11,086.6 | 11,193.3 | 10,913.8 |
| Inventories | 8,089.0 | 8,729.6 | 9,416.9 |
| Other Current Assets | 1,335.8 | 526.0 | 904.9 |
| Total Current Assets | 24,275.0 | 24,354.4 | 24,187.0 |
| Net Fixed Assets | 13,033.3 | 13,485.0 | 13,379.0 |
| Other Noncurrent Assets | 30,947.4 | 35,314.0 | 36,448.3 |
| Total Assets | 68,255.8 | 73,153.4 | 74,014.3 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 4,634.2 | 3,919.8 | 3,350.4 |
| Short-Term Debt | 2,503.3 | 2,134.0 | 8,817.8 |
| Other Current Liabilities | 7,221.0 | 6,806.3 | 7,332.2 |
| Total Current Liabilities | 14,358.5 | 12,860.1 | 19,500.4 |
| Long-Term Debt | 13,177.8 | 16,424.5 | 14,960.4 |
| Other Noncurrent Liabilities | 15,761.9 | 16,785.6 | 16,630.7 |
| Total Liabilities | 43,298.3 | 46,070.2 | 51,091.6 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 24,957.5 | 27,083.2 | 22,922.7 |
| Total Equity | 24,957.5 | 27,083.2 | 22,922.7 |
| Shares Outstanding (thou.) | 826,947.8 | 826,947.8 | 764,343.2 |
All amounts in millions of US Dollars except per share amounts.
Bayer AG Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 7,650 | 7,703 | 5,085 |
| Net Investing Cash Flow | (3,199.0) | (1,613.8) | (4,353.9) |
| Net Financing Cash Flow | (4,280.4) | (5,189.6) | (1,230.5) |
| Net Change in Cash | 171.0 | 900.0 | (499.0) |
| Depreciation & Amortization | 4,712.4 | 4,025.9 | 3,836.7 |
| Capital Expenditures | (2,006.4) | (2,257.3) | (2,479.3) |
| Cash Dividends Paid | (1,537.2) | (1,394.5) | (1,587.1) |
All amounts in millions of US Dollars except per share amounts.